Keefer David R 4
4 · Virios Therapeutics, Inc. · Filed Feb 1, 2021
Insider Transaction Report
Form 4
Keefer David R
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2021-01-28$7.80/sh+1,602$12,496→ 7,808 total(indirect: By LLC) - Exercise/Conversion
Warrant to Purchase Common Stock
[F2][F1]2021-01-28−1,602→ 0 total(indirect: By LLC)Exercise: $7.80From: 2020-12-16Exp: 2021-01-20→ Common Stock (1,602 underlying)
Footnotes (2)
- [F1]The securities are owned directly by Ethica Group, LLC ("Ethica"), the Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica.
- [F2]The Reporting Person provided notice of exercise to the Issuer on January 20, 2021 and the Company authorized the issuance of the shares pursuant to such exercise on January 28, 2020.
Signature
/s/ Greg Duncan, Attorney-in-Fact for David R. Keefer|2021-02-01